Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host-Reference-Cited by-同舟云学术

Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Published:2014-02-01 Issue:3 Volume:58 Page:309-318
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Rubin Lorry G.¹,Levin Myron J.²,Ljungman Per³⁴,Davies E. Graham⁵,Avery Robin⁶,Tomblyn Marcie⁷,Bousvaros Athos⁸,Dhanireddy Shireesha⁹,Sung Lillian¹⁰,Keyserling Harry¹¹,Kang Insoo¹²

Affiliation:

1. Division of Pediatric Infectious Diseases, Steven and Alexandra Cohen Children's Medical Center of New York of the North Shore-LIJ Health System, New Hyde Park

2. Section of Pediatric Infectious Diseases, University of Colorado Denver Anschutz Medical Campus, Aurora

3. Department of Hematology, Karolinska University Hospital

4. Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden

5. Department of Immunology, Great Ormond Street Hospital & Institute of Child Health, London, United Kingdom

6. Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland

7. Department of Blood and Marrow Transplant, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa

8. Department of Gastroenterology and Nutrition, Children's Hospital Boston, Massachusetts

9. Department of Allergy and Infectious Diseases, University of Washington, Seattle

10. Division of Hematology-Oncology, Hospital for Sick Children, Toronto, Ontario, Canada

11. Division of Pediatric Infectious Diseases, Emory University of School of Medicine, Atlanta, Georgia

12. Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut

Abstract

Abstract An international panel of experts prepared an evidenced-based guideline for vaccination of immunocompromised adults and children. These guidelines are intended for use by primary care and subspecialty providers who care for immunocompromised patients. Evidence was often limited. Areas that warrant future investigation are highlighted.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/58/3/309/34129460/cit816.pdf

Cited by 729 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101);2024-01-25

2. Approach to hematopoietic cell transplant candidates with respiratory viral detection;Frontiers in Pediatrics;2024-01-18

3. Improving the safety of CAR‐T‐cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B‐cell lymphoma undergoing CAR‐T‐cell therapy;American Journal of Hematology;2024-01-10

4. A novel protocol for de-isolating moderately and severely immunocompromised COVID-19 patients;Global Health & Medicine;2023-12-31

5. Documento de consenso de la Sociedad Española de Infectología Pediátrica y el Comité Asesor de Vacunas de la Asociación Española de Pediatría para la vacunación en inmunodeprimidos;Anales de Pediatría;2023-12